Search for: "Runnings v. Commissioner of Internal Revenue" Results 141 - 155 of 155
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Oct 2021, 6:41 pm by Shannon O'Hare
In the latter case, although the underlying assets are identical in substance, each NFT is still considered unique and will have its own identifiers to distinguish it from the other “editions” in the run. [read post]
22 Jan 2023, 9:01 pm by renholding
The New York DFS is seeking feedback on the proposed guidance and has indicated that the guidance is intended to align with the work of federal and international banking regulators on the management of climate-related financial risks. [read post]
6 Jan 2015, 4:14 am by Kevin LaCroix
As discussed here, in Public Employees’ Retirement System of Mississippi, v. [read post]
9 Sep 2011, 8:40 am by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
2 Oct 2010, 8:43 am by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
15 Feb 2012, 7:42 am by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
11 Feb 2011, 7:51 am by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
30 May 2012, 1:37 pm by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
22 Jun 2011, 7:09 am by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
14 Sep 2011, 12:07 pm by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
Rost, a former Pfizer vice president who turned whistleblower after he alleged that a subsidiary of the company started promoting off-label uses of various drugs, not only is in the running for FDA commissioner, but he has at least two congressmen in his corner.This week, the Web site Pharmalot reported that U.S. [read post]
3 Mar 2010, 7:33 pm by Adam Thierer
It has given us unprecedented access to public affairs information—local, state, national, and international. [read post]